These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
359 related items for PubMed ID: 29781567
21. Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report. Mercolini F, Merks JHM, Minard-Colin V, Cameron A, van Scheltinga SEJT, Sher O, Fichera G, Orbach D, Glosli H, Coppadoro B, Gallego S, Chisholm JC, Bisogno G. Pediatr Blood Cancer; 2023 Mar; 70(3):e30143. PubMed ID: 36519598 [Abstract] [Full Text] [Related]
22. Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies. Rogers T, Minard-Colin V, Cozic N, Jenney M, Merks JHM, Gallego S, Devalck C, Gaze MN, Kelsey A, Oberlin O, Stevens M, Spicer RD, Bergeron C, Martelli H. Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28205365 [Abstract] [Full Text] [Related]
23. Treatment of nonmetastatic cranial parameningeal rhabdomyosarcoma in children younger than 3 years old: results from international society of pediatric oncology studies MMT 89 and 95. Defachelles AS, Rey A, Oberlin O, Spooner D, Stevens MC. J Clin Oncol; 2009 Mar 10; 27(8):1310-5. PubMed ID: 19204197 [Abstract] [Full Text] [Related]
24. Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group. Orbach D, Mc Dowell H, Rey A, Bouvet N, Kelsey A, Stevens MC. Pediatr Blood Cancer; 2011 Dec 15; 57(7):1130-6. PubMed ID: 21495161 [Abstract] [Full Text] [Related]
25. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR. Heinz AT, Schönstein A, Ebinger M, Fuchs J, Timmermann B, Seitz G, Vokuhl C, Münter M, Pajtler KW, Stegmaier S, von Kalle T, Kratz CP, Ljungman G, Juntti H, Klingebiel T, Koscielniak E, Sparber-Sauer M, Cooperative Weichteilsarkom Studiengruppe. Pediatr Blood Cancer; 2024 Jan 15; 71(1):e30707. PubMed ID: 37814424 [Abstract] [Full Text] [Related]
26. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, Tridello G, Garaventa A, Pinkerton R, Stevens M. J Clin Oncol; 2004 Dec 01; 22(23):4787-94. PubMed ID: 15570080 [Abstract] [Full Text] [Related]
27. Is fertility-preservation safe for adult non-metastatic gynecologic rhabdomyosarcoma patients? Systematic review and pooled survival analysis of 137 patients. Elsebaie MA, Elsayed Z. Arch Gynecol Obstet; 2018 Mar 01; 297(3):559-572. PubMed ID: 29159540 [Abstract] [Full Text] [Related]
28. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL. Int J Gynecol Cancer; 2016 Jan 01; 26(1):141-8. PubMed ID: 26509850 [Abstract] [Full Text] [Related]
29. Embryonal rhabdomyosarcoma of the uterine corpus and cervix. Montag TW, D'ablaing G, Schlaerth JB, Gaddis O, Morrow CP. Gynecol Oncol; 1986 Oct 01; 25(2):171-94. PubMed ID: 3758828 [Abstract] [Full Text] [Related]
30. Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children. Flamant F, Gerbaulet A, Nihoul-Fekete C, Valteau-Couanet D, Chassagne D, Lemerle J. J Clin Oncol; 1990 Nov 01; 8(11):1847-53. PubMed ID: 2230871 [Abstract] [Full Text] [Related]
31. Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Gallego S, Zanetti I, Orbach D, Ranchère D, Shipley J, Zin A, Bergeron C, de Salvo GL, Chisholm J, Ferrari A, Jenney M, Mandeville HC, Rogers T, Merks JHM, Mudry P, Glosli H, Milano GM, Ferman S, Bisogno G, European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancer; 2018 Aug 01; 124(15):3201-3209. PubMed ID: 29797665 [Abstract] [Full Text] [Related]
32. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study. Vaarwerk B, van der Lee JH, Breunis WB, Orbach D, Chisholm JC, Cozic N, Jenney M, van Rijn RR, McHugh K, Gallego S, Glosli H, Devalck C, Gaze MN, Kelsey A, Bergeron C, Stevens MCG, Oberlin O, Minard-Colin V, Merks JHM. Cancer; 2018 Mar 01; 124(5):1016-1024. PubMed ID: 29211298 [Abstract] [Full Text] [Related]
33. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. Orbach D, Rey A, Oberlin O, Sanchez de Toledo J, Terrier-Lacombe MJ, van Unnik A, Quintana E, Stevens MC. J Clin Oncol; 2005 Jul 01; 23(19):4363-71. PubMed ID: 15994146 [Abstract] [Full Text] [Related]
34. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis. Terwisscha van Scheltinga CE, Spronk P, van Rosmalen J, Wijnen MH, Heij HA, van Baren R, Merks JH, van Noesel MM, Wijnen RM. J Pediatr Surg; 2014 Mar 01; 49(3):416-9. PubMed ID: 24650468 [Abstract] [Full Text] [Related]
35. Prognostic role of pleural effusion or ascites in localized rhabdomyosarcoma. Di Carlo D, Ferrari A, Toffolutti T, Milano GM, Manzitti C, Ruggiero A, Dall'Igna P, Melchionda F, Zanetti I, Scarzello G, Bisogno G. Pediatr Blood Cancer; 2019 Nov 01; 66(11):e27932. PubMed ID: 31385434 [Abstract] [Full Text] [Related]
36. Embryonal rhabdomyosarcoma of the uterine cervix. Koukourakis GV, Kouloulias V, Zacharias G, Maravelis G, Papadimitriou C, Platoni K, Gouliamos A. Clin Transl Oncol; 2009 Jun 01; 11(6):399-402. PubMed ID: 19531457 [Abstract] [Full Text] [Related]
37. Conservative management of uterine pediatric rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III and IV pilot. Corpron CA, Andrassy RJ, Hays DM, Raney RB, Wiener ES, Lawrence W, Lobe TE, Maurer HM. J Pediatr Surg; 1995 Jul 01; 30(7):942-4. PubMed ID: 7472949 [Abstract] [Full Text] [Related]
38. Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group. Aye JM, Xue W, Palmer JD, Walterhouse DO, Arnold MA, Heaton TE, Venkatramani R. Pediatr Blood Cancer; 2021 Apr 01; 68(4):e28914. PubMed ID: 33501771 [Abstract] [Full Text] [Related]
39. Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies. Schloemer NJ, Xue W, Qumseya A, Luo LY, Hiniker SM, Lautz TB, Rhee DS, Arnold MA, Venkatramani R. Pediatr Blood Cancer; 2024 Oct 01; 71(10):e31200. PubMed ID: 39016936 [Abstract] [Full Text] [Related]
40. Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies. Orbach D, Mosseri V, Gallego S, Kelsey A, Devalck C, Brenann B, van Noesel MM, Bergeron C, Merks JH, Rechnitzer C, Jenney M, Minard-Colin V, Stevens M. Head Neck; 2017 Jan 01; 39(1):24-31. PubMed ID: 27459057 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]